BLSC Bio-Logic Systems (MM)

Bio-logic Systems Corp. (Nasdaq:BLSC), a designer and marketer of computerized medical electrodiagnostic equipment and disposables, today announced the signing of a three-year agreement with Premier Purchasing Partners, L.P., the group purchasing division of Premier, Inc., one of the largest healthcare alliances in the U.S. Under the agreement, Bio-logic will offer sleep diagnostics equipment, services and accessories to Premier's affiliated hospital and healthcare systems. Commenting on the agreement, Roderick G. Johnson, president and chief operating officer of Bio-logic, stated, "It is estimated by Frost & Sullivan, a leading market consulting firm, that approximately 44 million people in the U.S. have a sleep disorder, impacting their quality of life and at times posing a hazard to their health and the safety of others, and that 30 million of those affected remain untested. People of all ages can be affected and most are unaware that they have a sleep disorder, and many of those who are aware have in the past chosen not to seek the help they need. "However, there is a growing awareness of sleep apnea monitoring on the part of both individuals and clinicians as a result of our aging and overweight population and studies linking hypertension to sleep apnea. For the period through 2011, Frost & Sullivan projects double-digit growth in the sleep service provider market, as well as a 13 percent increase in the number of sleep studies performed annually. "This agreement, with one of the nation's leading healthcare alliances, further confirms the leadership position that Bio-logic products have achieved in the sleep diagnostics arena. With the strong healthcare interest in sleep apnea monitoring, we are very pleased to have been chosen by Premier as one of three suppliers on this important contract," Johnson concluded. About Bio-logic Bio-logic Systems Corp., headquartered in Mundelein, IL, designs, develops, assembles and markets computer-based electrodiagnostic systems and related disposables for use by hospitals, clinics, school districts, universities and physicians. The systems conduct tests that are typically used by medical practitioners to aid in the diagnosis of certain neurological disorders, brain disorders and tumors and sensory disorders, including audiological and hearing screening and diagnosis. About Premier, Inc. Premier, Inc., a strategic alliance in U.S. healthcare, is owned by more than 200 of the nation's leading hospital and healthcare systems. These systems operate, or are affiliated with, nearly 1,500 hospital facilities and hundreds of healthcare sites. Premier provides an array of resources in support of healthcare services, including group purchasing, with more than $21 billion in annual sales of supplies and equipment. Other resources offered by Premier include insurance programs and performance improvement services of many kinds. Premier is headquartered in San Diego, CA, with other major facilities in Chicago, IL and Charlotte, NC. Advocacy and policy offices are located in Washington, DC. For more information, please visit www.premierinc.com. Cautionary Note Regarding Forward-Looking Statements This release contains forward-looking statements (as such term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934), including statements regarding growth in the sleep service provider market and sleep studies. Management has attempted to identify these forward-looking statements by using words such as "may," "will," "expects," "anticipates," "believes," "intends," "estimates," "could," "should," "projects" or similar expressions, but these words are not the exclusive way of identifying these statements. These forward-looking statements are based on information currently available to management and are subject to a number of risks, uncertainties and other factors that could cause Bio-logic's actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. These risks, uncertainties and other factors include general economic and business conditions, turnover in Bio-logic's sales force, lack of acceptance of new technology by clinicians and other healthcare professionals, the results of research and development efforts, technological changes, competition, potential changes in regulation by the FDA, costs relating to manufacturing of products, the timing of customer orders, the ability of certain suppliers to meet requirements and other factors detailed from time to time in Bio-logic's filings with the Securities and Exchange Commission. You should not place undue reliance on any forward-looking statements. Except as expressly required by the federal securities laws, Bio-logic undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changed circumstances or any other reason after the date of this release.